Trial Profile
Pharmacokinetic, pharmacodynamic and tolerability study of RCT-18 in Chinese patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Telitacicept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- 23 Dec 2015 New trial record